MX2021003137A - Metodo de preparacion de derivados de 4-metoxipirrol. - Google Patents

Metodo de preparacion de derivados de 4-metoxipirrol.

Info

Publication number
MX2021003137A
MX2021003137A MX2021003137A MX2021003137A MX2021003137A MX 2021003137 A MX2021003137 A MX 2021003137A MX 2021003137 A MX2021003137 A MX 2021003137A MX 2021003137 A MX2021003137 A MX 2021003137A MX 2021003137 A MX2021003137 A MX 2021003137A
Authority
MX
Mexico
Prior art keywords
pyrrole derivative
producing
methoxy pyrrole
methoxy
present
Prior art date
Application number
MX2021003137A
Other languages
English (en)
Inventor
Deok Ki Eom
Jeong Hyun Son
Jeong Taek Shin
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Priority claimed from PCT/KR2019/012122 external-priority patent/WO2020060213A1/ko
Publication of MX2021003137A publication Critical patent/MX2021003137A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente divulgación se refiere a un método de preparación de derivados de 4-metoxipirrol. La modalidad de la presente divulgación es útil para la producción industrial en masa de derivados de 4-metoxipirrol, ya que se mejoran el rendimiento y la eficiencia del procedimiento y se evita el uso de reactivos peligrosos y reactivos contaminantes para el medioambiente.
MX2021003137A 2018-09-19 2019-09-19 Metodo de preparacion de derivados de 4-metoxipirrol. MX2021003137A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (ko) 2018-09-19 2019-09-06 4-메톡시 피롤 유도체의 제조 방법
PCT/KR2019/012122 WO2020060213A1 (ko) 2018-09-19 2019-09-19 4-메톡시 피롤 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
MX2021003137A true MX2021003137A (es) 2021-05-14

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021003137A MX2021003137A (es) 2018-09-19 2019-09-19 Metodo de preparacion de derivados de 4-metoxipirrol.

Country Status (20)

Country Link
US (1) US20210221770A1 (es)
EP (1) EP3854784A4 (es)
JP (1) JP7253624B2 (es)
KR (1) KR102126576B1 (es)
AU (1) AU2019343857B2 (es)
BR (1) BR112021005156A2 (es)
CA (1) CA3110830A1 (es)
CL (1) CL2021000639A1 (es)
CO (1) CO2021003195A2 (es)
DO (1) DOP2021000042A (es)
EC (1) ECSP21019076A (es)
JO (1) JOP20210040A1 (es)
MA (1) MA53673A (es)
MX (1) MX2021003137A (es)
NZ (1) NZ773997A (es)
PE (1) PE20211736A1 (es)
PH (1) PH12021550523A1 (es)
RU (1) RU2763287C1 (es)
SG (1) SG11202101919VA (es)
TN (1) TN2021000035A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR20220088362A (ko) 2020-12-18 2022-06-27 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민을 포함하는 신규한 경구투여용 제제
KR102556500B1 (ko) * 2021-11-19 2023-07-19 하나제약 주식회사 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물
WO2023229323A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법
WO2023229322A1 (ko) * 2022-05-23 2023-11-30 일동제약(주) 6-메톡시피리딘-3-일 유도체의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336107B1 (en) * 2004-09-30 2015-09-23 Takeda Pharmaceutical Company Limited Proton pump inhibitors
WO2007114338A1 (ja) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited 酸分泌抑制薬
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
CN104718189B (zh) * 2012-11-19 2017-03-15 江苏豪森药业集团有限公司 吡咯磺酰类衍生物、其制备方法及其在医药上的应用
JP2017071553A (ja) * 2014-02-25 2017-04-13 味の素株式会社 ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
CN104447491B (zh) * 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
KR101613245B1 (ko) * 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
KR102081920B1 (ko) * 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
WO2017164575A1 (en) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine

Also Published As

Publication number Publication date
ECSP21019076A (es) 2021-05-31
CA3110830A1 (en) 2020-03-26
PE20211736A1 (es) 2021-09-06
BR112021005156A2 (pt) 2021-06-15
CL2021000639A1 (es) 2021-08-06
AU2019343857A1 (en) 2021-04-15
NZ773997A (en) 2024-03-22
US20210221770A1 (en) 2021-07-22
KR102126576B1 (ko) 2020-06-24
DOP2021000042A (es) 2021-05-31
CN112739684A (zh) 2021-04-30
EP3854784A1 (en) 2021-07-28
AU2019343857B2 (en) 2021-12-02
TN2021000035A1 (en) 2022-10-03
PH12021550523A1 (en) 2022-02-21
SG11202101919VA (en) 2021-04-29
CO2021003195A2 (es) 2021-04-08
KR20200033178A (ko) 2020-03-27
EP3854784A4 (en) 2022-03-30
RU2763287C1 (ru) 2021-12-28
MA53673A (fr) 2022-03-30
JOP20210040A1 (ar) 2021-03-07
JP7253624B2 (ja) 2023-04-06
JP2021535934A (ja) 2021-12-23

Similar Documents

Publication Publication Date Title
MX2021003137A (es) Metodo de preparacion de derivados de 4-metoxipirrol.
MX2019011778A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
MX2018001404A (es) Sistema de produccion/proceso de producción para acido acrilico y sus precursores.
WO2015026900A3 (en) Aerated composite materials, methods of production and uses thereof
WO2018124440A3 (ko) 신규한 이소프로필말레이트 신타제 변이체 및 이를 이용한 l-류신의 생산 방법
EA201171461A1 (ru) Получение налмефена гидрохлорида из налтрексона
EA201891668A1 (ru) Управление продуктом в процессах биологической конверсии
WO2010115201A3 (en) Reactor system and method for processing a process fluid
MX2016000634A (es) Metodo optimizado para la ruptura de paredes celulares de chlorella por medio de homogeneizacion a muy alta presion.
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
MX2020006306A (es) Método novedoso para producir 4,5-dihidroisoxazol 5,5-disustituido.
IN2014DN09394A (es)
BR112022006052A2 (pt) Processo para a preparação de protioconazol
BR112018004861A2 (pt) processo para purificação de hidrolisado de biomassa
MX2016000390A (es) Proceso para fabricar haloacetamidas.
MX2019005319A (es) Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo.
EA201992709A1 (ru) Способ получения оптически активного соединения
MX2015010934A (es) Metodo para producir un compuesto triciclico, y un compuesto triciclico capaz de producirse por dicho metodo de produccion.
SE1750819A1 (sv) A vertical lime kiln
WO2018007973A3 (en) Process and intermediates for preparing benzoxazepines
BR112021024852A2 (pt) Métodos de cultura de célula e composições para produção de anticorpo
EA202092707A1 (ru) Огнеупор, шихта для его получения, способ его получения, а также применение такого огнеупора
MA40702B1 (fr) Réacteur de carbonisation pour la production combinée de materiaux de construction et d'électricité à l'aide de la lumière solaire
MY195206A (en) Microorganisms For Production of O-Succinylhomoserine and Method for Production of O-Succinylhomoserine Using the Same
MX2016016075A (es) Metodo y composicion para mejorar la productividad de plantas no leguminosas.